RLYB
Rallybio Corporation - Common Stock (RLYB)
$31
About Rallybio Corporation - Common Stock (RLYB)
Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.
Details
Daily high
$0.33
Daily low
$0.31
Price at open
$0.32
52 Week High
$1.60
52 Week Low
$0.22
Market cap
12.8M
Dividend yield
0.00%
Volume
238,411
Avg. volume
321,131
P/E ratio
-.28
Rallybio Corporation - Common Stock News
Details
Daily high
$0.33
Daily low
$0.31
Price at open
$0.32
52 Week High
$1.60
52 Week Low
$0.22
Market cap
12.8M
Dividend yield
0.00%
Volume
238,411
Avg. volume
321,131
P/E ratio
-.28